Mexico - Delayed Quote MXN
Pfizer Inc. (PFE.MX)
446.20
+6.25
+(1.42%)
At close: April 24 at 1:58:26 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 12 | 22 | 21 |
| Avg. Estimate | 14.11B | 13.53B | 62.87B | 62.57B |
| Low Estimate | 13.32B | 13.32B | 60.89B | 59.17B |
| High Estimate | 15.25B | 13.88B | 64.59B | 66.72B |
| Year Ago Sales | 14.88B | 13.28B | 63.63B | 62.87B |
| Sales Growth (year/est) | -5.16% | 1.85% | -1.18% | -0.49% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PFE.MX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Neutral | 4/22/2025 |
| Maintains | UBS: Neutral to Neutral | 4/8/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 4/8/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/18/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/12/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/10/2025 |